Cerevel Therapeutics (CERE) Earnings Date, Estimates & Call Transcripts

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

$42.14

+0.54 (+1.30%)

(As of 04/18/2024 ET)

CERE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CERE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

Cerevel Therapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	1	($0.67)	($0.67)	($0.67)
Q2 2024	1	($0.63)	($0.63)	($0.63)
Q3 2024	1	($0.67)	($0.67)	($0.67)
Q4 2024	1	($0.69)	($0.69)	($0.69)
FY 2024	4	($2.66)	($2.66)	($2.66)

CERE Earnings Date and Information

Cerevel Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.

Cerevel Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/1/2024 Estimated)	-	-	-	-	-	-	-
11/1/2023	Q3 2023	($0.63)	($0.61)	+$0.02	($0.61)	-	-
8/2/2023	Q2 2023	($0.65)	($0.63)	+$0.02	($0.63)	-	-
5/3/2023	Q1 2023	($0.67)	($0.67)	-	($0.67)	-	-
2/22/2023	Q4 2022	($0.64)	($0.59)	+$0.05	($0.59)	-	-
11/8/2022	Q3 2022	($0.62)	($0.66)	($0.04)	($0.66)	-	-
8/1/2022	Q2 2022	($0.48)	($0.62)	($0.14)	($0.61)	-	-
Get the Latest News and Ratings for CERE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cerevel Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
5/10/2022	Q1 2022	($0.44)	($0.46)	($0.02)	($0.46)	-	-
3/1/2022	Q4 2021	($0.41)	($0.40)	+$0.01	($0.40)	-	-
11/10/2021	Q3 2021	($0.40)	($0.43)	($0.03)	($0.43)	-	-
8/11/2021	Q2 2021	($0.41)	($0.42)	($0.01)	($0.42)	-	-
5/16/2021	Q1 2021	($0.41)	($0.40)	+$0.01	($0.40)	-	-

Cerevel Therapeutics Earnings - Frequently Asked Questions

When is Cerevel Therapeutics's earnings date?: Cerevel Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on CERE's earnings history.
How much profit does Cerevel Therapeutics generate each year?: Cerevel Therapeutics (NASDAQ:CERE) has a recorded net income of -$432.84 million. CERE has generated -$2.50 earnings per share over the last four quarters.
What is Cerevel Therapeutics's EPS forecast for next year?: Cerevel Therapeutics's earnings are expected to decrease from ($2.53) per share to ($2.72) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:CERE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cerevel Therapeutics (CERE) Earnings Date, Estimates & Call Transcripts

CERE Earnings Estimates and Actuals by Quarter

CERE Estimated and Actual Revenue by Quarter

Cerevel Therapeutics Analyst EPS Estimates

CERE Earnings Date and Information

Cerevel Therapeutics Earnings History by Quarter

Cerevel Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info